Icon

INVANZ (nda021337)- (EQ 1GM BASE/VIAL)

ERTAPENEM SODIUM MSD SUB MERCK
EQ 1GM BASE/VIAL
Yes No
2017-Nov-15 Expired
None None
None No
INVANZ is a penem antibacterial indicated in adult patients and pediatric patients (3 months of age and older) for the treatment of the following moderate to severe infections caused by susceptible bacteria: • Complicated intra-abdominal infections. • Complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis. • Community-acquired pneumonia. • Complicated urinary tract infections including pyelonephritis. • Acute pelvic infections including postpartum endomyometritis, septic abortion and post-surgical gynecologic infections. INVANZ is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.
6 0 5
Total Other Developers 5
Drugs with Suitability No
EQ 1GM BASE/VIAL ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ******* **** ****** ******* *********** ****** ****** ********* ***** *********** **, ** & **, ******** **., ****** ****, *****, ****** (***) ***
****** *** ****** *** *** ****** *** *********** ****** *********** ****'****, ******, *** ******' * ******* (**) *****, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *** *********** **** - *, *-**** & *-****, ***** ********** ****, *****-***, *******, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** **** - *, *-**** & *-****, ***** ********** ****, *****-***, *******, ********* ******, ***** (***) ***
****** ***** ****** ******** ****** ******* ******* *** *********** ****-***, **** **.: **, ********** ***** ****** **** ****** *******, ******** ******, **********, ****** ******* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** **** *********** **** *********** ************** **., ***. *********** **.*** ******* ****, ******* ********, *****, ******** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.